- Vaccines
- Drugs
- Feed Additives
North America Poultry Drugs Market size is valued at USD x million in 2023 and is poised to grow at a CAGR of x% during the forecast period 2024-2030. North America Poultry Drugs Market report gives a comprehensive outlook across the globe with special emphasis on key countries such as United States and Canada. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, drug type, animal type and region. This report studies North America Poultry Drugs Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policy makers, and service providers engaged.
North America Poultry Drugs Market Dynamics
Drugs are the chemical substances used to diagnose, treat, prevent, or cure the various diseases. Poultry drugs are used to prevent or cure the various poultry diseases such as infectious diseases, gout, helminthiasis, and nutritional disorders among others. Rise in demand for health meat and eggs, increase in the R&D activities for the innovation of newer drugs, escalation in the prevalence of various infectious diseases, and high awareness about the poultry diseases and drugs in veterinary professionals are anticipated to boost the North America poultry drugs market. However, stringent regulatory policies for product approval, ban of antibiotics usage in poultry, high cost of R&D activities, and adverse effects associated with the drugs may restrain the growth of North America poultry drugs market over the forecast timeframe.
Country Analysis
United States dominates the market
Geographically, North America poultry drugs market is segmented into U.S. and Canada. U.S. poultry drugs market is growing due to increase in the R&D activities for the innovation of newer drugs, rise in prevalence infectious diseases, and increase in animal healthcare expenditure are boost the market.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2023-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis
North America Poultry Drugs Market Segmentation
By Product Type
By Drug Type
- Antibiotics
- Anti-gout Agents
- Anthelmintic
- Nutritional Supplements
- Anti-infectives
- Others
By Animal Type
- Turkey
- Chicken
- Goose
- Duck
- Others
Country
- U.S.
- Canada
Frequently Asked Questions
2023 is the base year and 2030 is the forecast year.
The North America poultry drugs market coverage are the United States, Canada
The North America poultry drugs market key players are the Zoetis (Pfizer, Inc.), Merck & Co. Inc., Virbac S.A., Boehringer Ingelheim Vetmedica, Elanco, Bayer Animal Health, Phibro Animal health Corporation, Zydus AHL, Ceva Sante Animale
| 1.Executive Summary |
| 2.North America Poultry Drugs Market Introduction |
| 2.1.North America Poultry Drugs Market - Taxonomy |
| 2.2.North America Poultry Drugs Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Drug Type |
| 2.2.3.Animal Type |
| 2.2.4.Country |
| 3.North America Poultry Drugs Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.North America Poultry Drugs Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.North America Poultry Drugs Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Vaccines |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Drugs |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Feed Additives |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.North America Poultry Drugs Market By Drug Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Antibiotics |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Anti-gout Agents |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Anthelmintic |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Nutritional Supplements |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Anti-infectives |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7.North America Poultry Drugs Market By Animal Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Turkey |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Chicken |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Goose |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Duck |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Poultry Drugs Market By Country, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. United States of America (USA) |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Canada |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 9.United States of America (USA) Poultry Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Vaccines |
| 9.1.2.Drugs |
| 9.1.3.Feed Additives |
| 9.2. Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Antibiotics |
| 9.2.2.Anti-gout Agents |
| 9.2.3.Anthelmintic |
| 9.2.4.Nutritional Supplements |
| 9.2.5.Anti-infectives |
| 9.2.6.Others |
| 9.3. Animal Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Turkey |
| 9.3.2.Chicken |
| 9.3.3.Goose |
| 9.3.4.Duck |
| 9.3.5.Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.Canada Poultry Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Vaccines |
| 10.1.2.Drugs |
| 10.1.3.Feed Additives |
| 10.2. Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Antibiotics |
| 10.2.2.Anti-gout Agents |
| 10.2.3.Anthelmintic |
| 10.2.4.Nutritional Supplements |
| 10.2.5.Anti-infectives |
| 10.2.6.Others |
| 10.3. Animal Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Turkey |
| 10.3.2.Chicken |
| 10.3.3.Goose |
| 10.3.4.Duck |
| 10.3.5.Others |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11. Competition Landscape |
| 11.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 11.2.1.Zoetis (Pfizer, Inc.) |
| 11.2.2.Merck & Co. Inc. |
| 11.2.3.Virbac S.A. |
| 11.2.4.Boehringer Ingelheim Vetmedica |
| 11.2.5.Elanco |
| 11.2.6.Bayer Animal Health |
| 11.2.7.Phibro Animal health Corporation |
| 11.2.8.Zydus AHL |
| 11.2.9.Ceva Sante Animale |
| 12. Research Methodology |
| 13. Appendix and Abbreviations |
- Zoetis (Pfizer, Inc.)
- Merck & Co. Inc.
- Virbac S.A.
- Boehringer Ingelheim Vetmedica
- Elanco
- Bayer Animal Health
- Phibro Animal health Corporation
- Zydus AHL
- Ceva Sante Animale